The effect of obesity on the association between liver fat and carotid atherosclerosis in a multi-ethnic cohort.

OBJECTIVE Non-alcoholic fatty liver disease is the most common liver disorder in Western society, increasing in parallel with obesity and the metabolic syndrome. Evidence suggests that there is an independent relationship between liver fat (LF) and atherosclerosis, however it is unknown if this applies to low risk populations. The purpose of this study was to evaluate the association between LF and measures of sub-clinical carotid atherosclerosis in men and women of Aboriginal, Chinese, European, and South Asian origin. METHODS AND RESULTS Healthy men and women were assessed for LF (computed tomography scan) and atherosclerosis (carotid ultrasound) in addition to cardiovascular risk factors, demographics, and body composition. Liver Hounsfield units (HU) values were negatively correlated with age, BMI, waist circumference (WC), percent body fat, carotid intima media thickness total plaque area, and total area. LF was significantly associated with carotid IMT and total area after adjustment for sex, age, ethnicity, education, income and smoking status. However after adjusting for BMI and WC, LF was no longer significantly associated with atherosclerosis. CONCLUSION Increased LF may be associated with atherosclerosis, however, after adjustment for body composition, LF was not significantly associated with sub-clinical atherosclerosis. BMI and WC are useful anthropometric measures for the evaluation of CVD risk independent of LF.

[1]  R. Sacco,et al.  Genetic and Environmental Contributions to Carotid Intima-Media Thickness and Obesity Phenotypes in the Northern Manhattan Family Study , 2004, Stroke.

[2]  D. Kim,et al.  Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. , 2009, Atherosclerosis.

[3]  A. Lonardo,et al.  Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis. , 2008, Clinical science.

[4]  J. Ludwig,et al.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.

[5]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[6]  A. Ignaszewski,et al.  The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. , 2003, Journal of the American College of Cardiology.

[7]  J. Hirschhorn,et al.  Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study , 2008, Journal of gastroenterology and hepatology.

[8]  J. Frohlich,et al.  Detection of early atherosclerosis with B mode carotid ultrasonography: assessment of a new quantitative approach. , 1999, Clinical and investigative medicine. Medecine clinique et experimentale.

[9]  R. Farah,et al.  Presence of coronary plaques in patients with nonalcoholic fatty liver disease. , 2010, Radiology.

[10]  J. Takeda,et al.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. , 2007, World journal of gastroenterology.

[11]  A. Lonardo,et al.  Should Nonalcoholic Fatty Liver Disease Be Renamed? , 2005, Digestive Diseases.

[12]  P. Toth Impact of Abdominal Visceral and Subcutaneous Adipose Tissue on Cardiometabolic Risk Factors: The Jackson Heart Study , 2011 .

[13]  S. Lear,et al.  Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). , 2007, The American journal of clinical nutrition.

[14]  S. Curley,et al.  Comparison of CT methods for determining the fat content of the liver. , 2007, AJR. American journal of roentgenology.

[15]  A. Mohammadi,et al.  Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease , 2011, Vascular health and risk management.

[16]  A. Lonardo,et al.  Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: a novel approach to reduce cardiovascular risk? , 2011, Archives of medical research.

[17]  Chantal Martineau,et al.  Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk , 2005, Canadian Medical Association Journal.

[18]  S. O’Rahilly,et al.  The perils of portliness: causes and consequences of visceral adiposity. , 2000, Diabetes.

[19]  S. Şahin,et al.  The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome Metabolik sendromlu hastalarda alkole bağli olmayan karaciğer yağlanmasi ile koroner arter hastaliğinin ciddiyeti arasindaki ilişki , 2008 .

[20]  R. Heine,et al.  Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus , 2005, European journal of clinical investigation.

[21]  A. Zanchetti,et al.  Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study , 2007, Journal of Human Hypertension.

[22]  G. Marchesini,et al.  Prevention and treatment of nonalcoholic fatty liver disease. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[23]  P. Björntorp "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. , 1990, Arteriosclerosis.

[24]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[25]  M. Koplay,et al.  Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography. , 2009, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[26]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[27]  W. Salt,et al.  Nonalcoholic fatty liver disease (NAFLD): a comprehensive review. , 2004, Journal of insurance medicine.

[28]  S. Lear,et al.  Study design of the Multicultural Community Health Assessment Trial (M-CHAT): a comparison of body fat distribution in four distinct populations. , 2006, Ethnicity & disease.

[29]  聖史 赤羽目 Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT) , 2009 .